Future research needs for angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), or direct renin inhibitors (DRIs) for treating hypertension identification of future research needs from Comparative effectiveness review no. 34
Almost 75 million American adults have hypertension. Advances in antihypertensive therapy have dramatically reduced cardiovascular, cerebrovascular, and renal events. Among the effective pharmacotherapies are inhibitors of the renin-angiotensin-aldosterone system (RAS).
Main Author: | |
---|---|
Corporate Authors: | , , |
Format: | eBook |
Language: | English |
Published: |
Rockville, MD
Agency for Healthcare Research and Quality
[2012], 2012
|
Series: | Future research needs paper
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references